Deep Genomics logo

Deep Genomics

109 employees · est. 2014 · Toronto, Canada

VS
Enable Medicine logo

Enable Medicine

Spatial and multimodal insights powered by AI for your next therapeutic breakthrough.

15 employees · est. 2019 · Menlo Park, United States

Deep Genomics is the older company (2014 vs 2019); Deep Genomics is the larger of the two.

Side-by-Side Comparison

Deep Genomics Enable Medicine
Founded
2014 older 2019
Headquarters
Toronto, Canada Menlo Park, United States
Employees
109 larger 15
Industry
AI, Biotechnology, Health and Wellness Biotechnology, Pharmaceutical
Funding Stage
Series C Acquired
Total Funding
$236.70M $63.62M
Funding Rounds
6 3
Services
AI model refinement, molecular target identification, drug development acceleration, data asset generation, software systems for biotech Multimodal data integration, Spatial proteomics analysis, Biological data optimization, AI-powered insights generation, High-resolution single cell data analysis, Patient-relevant decision support
Target Customers
pharmaceutical companies, biotechnology researchers, medical scientists, healthcare innovators Biopharma companies, Academic institutions, Healthcare providers, Research scientists, Drug development teams
Taxonomy
Genetic Therapies, Biology, Genomics, Drug Development, Molecular Biology, Disease Detection, Treatment, Expert Recruitment Spatial Biology, Multimodal Insights, Drug Target Discovery, Biomarker Identification, Therapeutic Strategy Development, High-Parameter Biological Data, Cloud-Based Operating System, Oncology Research, Autoimmune Disease Research, Collaborative Research Network, Biological Data Mapping, Data Generation And Analysis, Interdisciplinary Team, Healthcare Innovation
Website
deepgenomics.com enablemedicine.com
Deep Genomics logo

About Deep Genomics

Deep Genomics, founded in 2014 and headquartered in Canada, operates at the forefront of AI, Biotechnology, and Health and Wellness. The company is revolutionizing drug discovery by developing the Biological Foundation (BioFM) Model Platform, designed to enhance molecular design and target biology,...

Enable Medicine logo

About Enable Medicine

Enable Medicine, founded in 2019, is a pioneering force at the intersection of Biotechnology and Pharmaceutical industries. With headquarters in the United States, the company leverages cutting-edge AI to provide spatial and multimodal insights for therapeutic breakthroughs. Their key innovation lie...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Deep Genomics and Enable Medicine — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Deep Genomics and Enable Medicine — by email.

Frequently Asked Questions

Deep Genomics. Enable Medicine — Spatial and multimodal insights powered by AI for your next therapeutic breakthrough.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Deep Genomics has raised $236.70M while Enable Medicine has raised $63.62M.
Deep Genomics and Enable Medicine operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Deep Genomics with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy